In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rodaris Pharmaceuticals Ltd.

Latest From Rodaris Pharmaceuticals Ltd.

Recent Dealmaking (06/2003)

Summarizing the month in European dealmaking.

The Battle For the Bulging

Despite disappointments in the hunt for effective fat-busting drugs, this large and seemingly ever-growing market is encouraging companies to continue to rise to the challenge of a disease that is a host of interacting disorders.
BioPharmaceutical Platform Technologies

UCL Ventures (University College London)

Spin-out activity at UCL Ventures was jump-started by the success of one company, SR Pharma, during the late nineties. The tech transfer office now takes advantage of London's status as a business and financial center to find and develop new entrepreneurs, and continues to benefit from UK government seed funds.
BioPharmaceutical Strategy

Rademacher Group LTD

Scientists at Rademacher Group are trying to elucidate the molecular mechanisms of glucose control.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Rademacher Group Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Rodaris Pharmaceuticals Ltd.
  • Senior Management
  • Michael Kilpatrick, PhD, CEO
    Irene Francois, PhD, Dir., R&D
    Alex B Watson, Dir., Bus. Dev.
  • Contact Info
  • Rodaris Pharmaceuticals Ltd.
    Phone: (44) 1865 783 600
    3 Robert Robinson Ave.
    Florey House
    Oxford, OX4 4GA